Dermatophytosis Treatment Market Size

Dermatophytosis Treatment Market size was valued at USD 9.27 billion in 2024 and is likely to cross USD 17.05 billion by 2037, expanding at more than 4.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of dermatophytosis treatment is estimated at USD 9.65 billion.

The growth of the dermatophytosis treatment market can be attributed to the growing population of people with weak immune systems, and rising incidences of sedentary lifestyle among people. Along with these, increasing geriatric population contributing to the high occurrence of dermatophytosis across the globe is also expected to significantly raise the demand for the treatment in the forthcoming years. According to the World Health Organization, between 2015 to 2050, the percentage of the world’s population aged 60 years and older will nearly double from 12 percent to 22 percent. In 2050, 80% of older people will be living in low- and middle-income countries.

Upsurge in the number of hospital-acquired diseases is also predicted to expand the market in the near future. Furthermore, escalating private investments for conducting research and development activities to develop novel treatment in developed nations, and rise in healthcare funding are assessed to offer profitable opportunities for dermatophytosis treatment market growth in the imminent time.